Original Article
Immuno-regulated common markers but different network signatures in two associated cancers: evidences from epigenetic treatment
Annals of Translational Medicine
2016;
4
(5)
:86
(March 2016)
Chest CT abnormalities and quality of life: relationship in adult cystic fibrosis
Annals of Translational Medicine
2016;
4
(5)
:87
(March 2016)
Analysis of the height dependence of site-specific cancer risk in relation to organ mass
Annals of Translational Medicine
2016;
4
(5)
:88
(March 2016)
Review Article
Thoracic surgical training in Europe: what has changed recently?
Annals of Translational Medicine
2016;
4
(5)
:89
(March 2016)
Objective and quantitative assessment of motor function in Parkinson’s disease—from the perspective of practical applications
Annals of Translational Medicine
2016;
4
(5)
:90
(March 2016)
Big-data Clinical Trial Column1
Univariate description and bivariate statistical inference: the first step delving into data
Annals of Translational Medicine
2016;
4
(5)
:91
(March 2016)
Editorial
Biological samples transportation by drones: ready for prime time?
Annals of Translational Medicine
2016;
4
(5)
:92
(March 2016)
Getting to the core of fibrosis: targeting redox imbalance in aging
Annals of Translational Medicine
2016;
4
(5)
:93
(March 2016)
Radiotherapy: killing with complement
Annals of Translational Medicine
2016;
4
(5)
:94
(March 2016)
Combination therapy with TLR7 agonist and radiation is effective for the treatment of solid cancer
Annals of Translational Medicine
2016;
4
(5)
:95
(March 2016)
Mutations at the splice sites of exon 14 of MET gene: a new target for sarcomatoid carcinomas?
Annals of Translational Medicine
2016;
4
(5)
:96
(March 2016)
Has MET met its match?
Annals of Translational Medicine
2016;
4
(5)
:97
(March 2016)
Perspective
Management of lower pole renal stones: the devil is in the details
Annals of Translational Medicine
2016;
4
(5)
:98
(March 2016)
Commentary
Assessing the cardiovascular risk of hormonal therapy in patients with prostate cancer
Annals of Translational Medicine
2016;
4
(5)
:99
(March 2016)
Combination therapy for metastatic renal cell carcinoma
Annals of Translational Medicine
2016;
4
(5)
:100
(March 2016)
A novel role of hepatic epithelial transforming growth factor-β signaling in cholangiocarcinogenesis
Annals of Translational Medicine
2016;
4
(5)
:101
(March 2016)
Letter to the Editor
Mining of single nucleotide polymorphisms in the 3' untranslated region of liver cancer-implicated miR-122 target genes
Annals of Translational Medicine
2016;
4
(5)
:102
(March 2016)
Disclosure:
1. The series “Big-data Clinical Trial Column” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding.